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Original articleDeletion of miRNA processing enzyme Dicer
in POMC-expressing cells leads to pituitary
dysfunction, neurodegeneration and development
of obesityMarc Schneeberger 1,2,3, Jordi Altirriba 4, Ainhoa Garcı́a 1,2, Yaiza Esteban 1,2, Carlos Castaño 1,2,
Montserrat Garcı́a-Lavandeira 5, Clara V. Alvarez 5, Ramon Gomis 1,2,3, Marc Claret 1,2,*ABSTRACTMicroRNAs (miRNAs) have recently emerged as key regulators of metabolism. However, their potential role in the central regulation of whole-body
energy homeostasis is still unknown. In this study we show that the expression of Dicer, an essential endoribonuclease for miRNA maturation, is
modulated by nutrient availability and excess in the hypothalamus. Conditional deletion of Dicer in POMC-expressing cells resulted in obesity,
characterized by hyperphagia, increased adiposity, hyperleptinemia, defective glucose metabolism and alterations in the pituitary–adrenal axis.
The development of the obese phenotype was paralleled by a POMC neuron degenerative process that started around 3 weeks of age.
Hypothalamic transcriptomic analysis in presymptomatic POMCDicerKO mice revealed the downregulation of genes implicated in biological
pathways associated with classical neurodegenerative disorders, such as MAPK signaling, ubiquitin–proteosome system, autophagy and
ribosome biosynthesis. Collectively, our results highlight a key role for miRNAs in POMC neuron survival and the consequent development of
neurodegenerative obesity.
& 2012 Elsevier GmbH. All rights reserved.
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MicroRNAs (miRNAs) are short, non-coding RNAs that have recently
emerged as key posttranscriptional regulators. The biogenesis of the
majority of miRNAs is achieved through a canonical process by which
long primary transcripts undergo nuclear processing by the enzymes
Drosha and DGCR8 to produce stem-loop precursors (pre-miRNAs) [1].
These pre-miRNAs are exported to the cytoplasm and further processed
by a complex containing Dicer. The activity of Dicer is essential for
producing the mature form of miRNAs that eventually enter the miRNA-
induced silencing complex (miRISC) [1]. In general lines, miRNAs
interact with the 30 untranslated region (UTR) of specific target mRNAs
in a sequence-specific manner causing repression of protein translation
and/or degradation of mRNA [2].
Functional studies are beginning to reveal relevant roles for miRNAs in
a number of biological processes and their involvement in pathologicalhttp://dx.doi.org/10.1016/j.molmet.2012.10.001
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74 MOLECULAR METABconditions such as heart diseases, cancer, metabolic conditions
and neurological disorders [3,4]. In the central nervous system (CNS),
the study of cell and regional-specific deletions of Dicer using the cre/
lox system resulted in a wide range of anatomical and behavioral
phenotypes, but overall revealed a fundamental role for miRNAs in
neural cell proliferation, differentiation and survival [5–9]. Furthermore,
different timings of Dicer deletion indicated the activation of time-
dependent functions of miRNAs [10,11]. Collectively, these reports
highlight the importance of miRNAs in neuronal development and the
activation of different programs during embryonic or post-natal life.
The hypothalamus is a key CNS area implicated in the regulation of
whole-body energy homeostasis [12]. The regulation of this biological
process is achieved through a complex sensing of hormones and
nutrient-related signals, followed by its integration and coordination
of precise neurochemical and neurophysiological responses. These
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neurons of the arcuate nucleus of the hypothalamus (ARC). In particular,
neurons co-expressing orexigenic neuropeptides agouti-related protein
(AgRP) and neuropeptide Y (NPY), along with neurons co-expressing
anorexigenic pro-opiomelanocortin (POMC) precursor and cocaine and
amphetamine-related transcript (CART), have been extensively impli-
cated in the regulation of appetite, body weight, glucose and lipid
metabolism [12–14]. Interestingly, recent studies suggest important
functions for miRNAs upon metabolic regulation in peripheral tissues
such as liver [15], adipose tissue [16] and pancreas [17], but have not
investigated their role in hypothalamic neurons involved in energy
homeostasis control.
Here we demonstrate that Dicer is expressed in relevant ARC neurons
implicated in energy balance and that its expression is regulated by
nutrient availability. Furthermore, our data also shows that ablation of
Dicer-dependent miRNAs in POMC-expressing cells leads to pituitary
dysplasia, adrenal hypofunction and neurodegenerative obesity.2. MATERIALS AND METHODS
2.1. Animals and diets
C57Bl/6 and ob/ob mice were purchased from Harlan Europe. Indicator
mice were generated by crossing POMC-cre mice [18,19] with Z/EG
mice [20] and AgRP-cre mice [18,19] with ROSA26-YFP mice [21].
To generate mice lacking Dicer specifically in POMC neurons, POMC-cre
mice were mated with mice carrying a loxP-flanked Dicer1 allele
(Jackson Laboratory, Bar Harbor, USA). Mouse colonies were main-
tained by breeding male POMCþ / DicerloxP/loxP with female POMC /
DicerloxP/loxP. Mice were maintained on a 12 h-light/12 h-dark cycle
with free access to water and standard chow (2014; Teklad).
Diet-induced obesity (DIO) was achieved by the administration of
high-fat diet (D12451; 45% Kcal derived from fat, Research Diets,
New Brunswick, USA) to male C57Bl/6 at 6 weeks of age for 12
consecutive weeks. All animal procedures were approved by the Animal
Experimentation Ethics Committee of the University of Barcelona and
performed according to European Community and local guidelines.
2.2. In vivo physiological studies
Body weights were measured weekly. Food intake was measured in
singly-housed mice for 5 consecutive days. For fast-refeeding studies,
mice were fasted for 16 h and refed with a pre-weight amount of chow.
Food intake was measured at the indicated time points. Adiposity
was measured as epididymal fat-pad weight in relation to total body
weight and expressed as percentage. Blood trygliceride concentration
was assessed using the Accutrend Plus GCT system (Roche Diagnos-
tics, Spain). Blood glucose levels were determined using a glucometer
(Arkray, Shiga, Japan). Glucose-tolerance tests were conducted in
16 h-fasted mice by intraperitoneal (IP) administration of glucose
(2 g/Kg). Area under the curve was calculated above baseline glucose.
Insulin sensitivity tests were performed in 4 h-food deprived mice by IP
administration of insulin (0.375 UI/Kg). ELISA kits were used to
determine plasma insulin and leptin (Crystalchem Inc., Downers Grove,
USA), corticosterone (Immuno Diagnostic System, Germany) and
catecholamines (Labor Diagnostika Nord, Germany).
2.3. Hypothalamic immunohistochemistry
Mice were transcardially perfused with 4% paraformaldehyde, over-
night fixed, cryoprotected in 30% sucrose and frozen. Brains were cut
into 25 mm-thick slices using a sliding microtome and immunohisto-
chemistry performed as previously described [22,23]. Antibodies usedMOLECULAR METABOLISM 2 (2013) 74–85 & 2012 Elsevier GmbH. All rights reserved. www.molecwere: anti-Dicer (1:100, Santa Cruz Biotechnology, Santa Cruz, USA),
anti-POMC (1:1000, Phoenix Pharmaceuticals, Burlingame, USA)
and anti-rabbit Alexa Fluor 488 or 595 (1:400, Molecular Probes,
Grand Island, USA). Imaging was performed using a Leica DMI6000B
microscope.
2.4. Neuron counts
Sections throughout the ARC from control and POMCDicerKO mice were
collected in 3 series as described [22]. The distribution and number of
POMC neurons were counted in one series in a blinded fashion. This
result was multiplied by 3 to account for the 3 series.
2.5. Pituitary and adrenal gland immunohistochemistry
Pituitaries and adrenals from 4% paraformaldehyde-perfused mice
were fixed overnight and maintained in 70% ethanol until paraffin
inclusion. To prevent staining variations from slide to slide, 3 mm
sections of 3 controls and 3 POMCDicerKO mice were mounted in
parallel in the same slide and stained with Haematoxylin–Eosin [24].
For immunohistochemistry, antigens were recovered with microwave
treatment (5 pulses 5 min/each) in TE buffer and Envision kit (DAKO,
Glostrup, Denmark) for blocking. Primary antibodies were incubated for
1 h at 37 1C (anti-ACTH) or overnight at 4 1C (all other antibodies).
Antibodies used were: monoclonal anti-ACTH (1:3000, DAKO) and rabbit
(National Institute of Diabetes and Digestive and Kidney diseases) anti-
GH (1:3000), anti-PRL (1:1500), anti-TSH (1:1000), anti-LH (1:10,000)
and anti-FSH (1:4000).
2.6. RNA purification and gene expression analysis by quantitative
real-time PCR (qPCR).
Hypothalami and pituitaries were harvested and immediately frozen in
liquid nitrogen. mRNA was isolated using Trizol (Invitrogen, Carlsbad, USA).
Retrotranscription was performed in 1 mg of RNA using the Taqman
Retrotranscription kit (Applied Biosystems, Foster City, USA). QPCR was
carried out using proprietary Taqman gene expression assays (Applied
Biosystems) for Dicer (Mm00521715_m1), Drosha (Mm01310009_
m1), Dgcr8 (Mm01146851_m1), Ago2 (Mm00838341_m1), Agrp
(Mm00475829_g1), Cart (Mm00489086_m1), Pomc (Mm00435874_m1),
Npy (Mm00445771_m1), Crh (Mm01293920_s1), Mc3r (Mm00434876_s1),
Mc4r (Mm00457483_s1), Tpit (Mm00453377_m1), Pit1 (Mm00476852_
m1), Crhr1 (Mm00432670_m1), Gh (Mm01258409_g1), Tshb
(Mm00437190_m1), Ntrk2 (Mm00435422_m1), Myc (Mm00487804_m1),
Naglu (Mm00479175_m1), Acp2 (Mm00651503_m1), Nhlrc1
(Mm00614667_s1), Park2 (Mm00450186_m1), Rps24 (Mm01623058_s1)
and Rps9 (Mm00850060_s1). Probes for Hprt (Mm00446968_m1) or Gapdh
(Mm99999915_g1) were used to adjust for total RNA content. mRNA levels
were measured using the ABI Prism 7900 HT system (Applied Biosystems).
2.7. Global transcriptomic analysis
Total RNA was extracted from hypothalamic microdissections of
2-week old control and POMCDicerKO mice using the miRNAeasy mini
kit (Qiagen, Venlo, The Netherlands) and RNeasy micro spin columns
(Qiagen). RNA was hybridized to mouse 430 2.0 genechips (Affymetrix,
Santa Clara, USA). Background adjustment, normalization and data
summarization were performed by evaluation of .cell files by Robust
Multi-array Analysis (RMA) [25] using the Affy package [26] from
bioconductor [27] on R language. Raw and processed data passed
successfully several quality controls as described previously [28].
In order to increase the sensitivity of the analysis and reduce
background noise, those genes that were called Absent (calculated
with the MAS5 algorithm from the simpleAffy package [29] in atularmetabolism.com 75
Original articleleast two microarrays in both experimental groups) were removed.
Differentially expressed genes were considered when presented a
t-student P-valuer0.05. Those genes were represented in a heatmap
using dChip software [30] and KEGG pathway analysis was per-
formed with DAVID Bioinformatic tool [31,32], which provides typical
gene-term analysis to identify relevant biological pathways associated
with a particular gene list. Raw and processed data has been deposited
in GEO database with the accession number GSE38672.
2.8. Statistics
Data are expressed as mean7SEM. P values were calculated using non-
parametric Mann–Whitney test. Pr0.05 was considered significant.Figure 1: Dicer is expressed in the mediobasal hypothalamus and is modulated by nutrient availability. Representative immunofluo
6 control mice. (D–F) Representative immunofluorescence images of the ARC from indicator POMC-Z/EG mice, showing POMC ne
from indicator AgRP-YFP mice, showing AgRP neurons (G, green), Dicer staining (H, red) and merged images (I). Arrows show co
the hypothalamus. Scale bars: 100 mm. 3V: third ventricle. (J) Expression analysis of miRNA processing enzymes in the hypothala
qPCR. (K) Expression analysis of miRNA processing enzymes in the hypothalamus of 18-week old male DIO C57Bl/6 control mice
for total RNA content. Data are expressed as mean7SEM. *Po0.05; ns: not significant. (For interpretation of the reference
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3.1. Dicer is expressed in hypothalamic POMC and AgRP neurons
To initially investigate a potential role for Dicer in the central regulation
of energy balance, we assessed its anatomical distribution in the
hypothalamus of control C57Bl/6 mice by immunohistochemistry. Dicer
protein was broadly expressed in medial hypothalamic areas implicated
in energy homeostasis control, including the paraventricular, lateral and
ventromedial hypothalamus (Figure 1A–C). We next asked whether
Dicer was expressed in POMC and AgRP neurons. To address this
question, we generated mice expressing green fluorescent protein
(GFP) or yellow fluorescent protein (YFP) specifically in POMC or AgRPrescence images of Dicer staining (red) in the paraventricular (A), lateral (B) and ventromedial (C) hypothalamus of male C57Bl/
urons (D, green), Dicer staining (E, red) and merged images (F). (G–I) Representative immunofluorescence images of the ARC
localization. PVN: paraventricular nucleus. LH: lateral hypothalamus. VMH: ventromedial hypothalamus. ARC: arcuate nucleus of
mus of 12-week old male C57Bl/6 control mice under fed and fasting (24h) conditions (n¼11–12 mice/group) assessed by
and ob/ob mice (n¼5–7 mice/group) under fasting (24 h) conditions assessed by qPCR. Probe for Hprt was used to adjust
s to color in this figure legend, the reader is referred to the web version of this article.)
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neurons and performed Dicer colocalization studies. The specificity of
Dicer antibody was previously reported [33] and omission of primary
antibody in our experimental settings produced no signal (data not
shown). Consistent with a ubiquitous expression of Dicer, we found
colocalization in most POMC (93.670.2%, Figure 1D–F) and AgRP
neurons (93.871.5%, Figure 1G–I). These results indicate that Dicer is
expressed in key hypothalamic nuclei and neuron populations impli-
cated in energy homeostasis control.
3.2. Dicer expression in the hypothalamus is regulated by nutrient
availability
Next, we assessed whether hypothalamic Dicer expression was
modulated by acute changes in nutrient availability in 12-week old male





























































Figure 2: POMCDicerKO mice exhibit increased body weight.(A) Body weight profiles of male control and POMCDicerKO mice.
refeeding test in 12–14 week old male control and POMCDicerKO mice. eWAT: epididymal white adipose tissue. BW: body w
MOLECULAR METABOLISM 2 (2013) 74–85 & 2012 Elsevier GmbH. All rights reserved. www.molecmRNA in the hypothalamus, as expression of other miRNA biogenesis
genes (Dgcr8, Drosha and Argonaute 2 (Ago2, a core component of the
miRISC complex)) was unaltered (Figure 1J) and Dicer transcript was
unchanged in other brain areas such as the hindbrain (Fed: 10076%;
Fasted: 112714%; n¼5–6 mice/group, NS).
We also examined the effect of nutrient excess upon the hypothalamic
expression of the same genes in diet-induced (DIO) and genetic (ob/ob)
models of obesity. At the time of the study (18 weeks of age), both
experimental models exhibited obesity, fasting hyperglycemia and
glucose intolerance (Supplementary Figure 1). Dicer expression was
reduced in hypothalami from both fasted DIO and ob/ob mice when
compared to control mice under the same nutritional status (Figure 1K).
No significant changes were seen in the expression of Dgcr8, Drosha










































































Time after refeeding (h)
(B) Epididymal fat weight relative to body weight, (C) plasma leptin, (D) blood triglycerides, (E) daily food intake and (F) fast-
eight. Data are expressed as mean7SEM. N¼6–8 mice/genotype. *Po0.05; **Po0.01; ***Po0.001.
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Figure 3: POMCDicerKO mice exhibit glucose metabolism alterations. (A) Blood glucose levels under fed and fasting conditions and (B) fasting plasma insulin in 12–14 week-old male control and POMCDicerKO mice. Glucose metabolism was assessed by
(C) glucose tolerance and (D) insulin sensitivity tests in 12–14 week-old male control and POMCDicerKO mice. (E) Blood glucose levels under fed and fasting conditions and (F) fasting plasma insulin in 6 week-old male control and POMCDicerKO mice.
Glucose metabolism was assessed by (G) glucose tolerance and (H) insulin sensitivity tests in 6 week-old male control and POMCDicerKO mice. Data are expressed as mean7SEM. N¼6–8 mice/genotype. *Po0.05; **Po0.01; ***Po0.001.
Original article
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expression is modulated by nutrient availability and that might be a
physiologically relevant enzyme implicated in the hypothalamic control
of energy balance.
3.3. Dicer deficiency in POMC-expressing cells leads to energy
homeostasis alterations
To further understand the role of hypothalamic miRNAs upon whole-
body energy balance control, we crossed POMC-cre mice [18,19] with
floxed Dicer mice [34] to generate animals lacking Dicer in POMC
neurons (hereafter referred as POMCDicerKO). Dicer mRNA expression
was significantly decreased in the hypothalamus from 12-week
old (control: 10076%; POMCDicerKO: 7775%; n¼6 mice/genotype,
Po0.01 mutant mice, confirming appropriate tissue-specific reduction).
Postnatal POMCDicerKO mice appeared to be normal, showing
equivalent body weights as compared with control littermates
(Figure 2A). However, from 6 weeks of age onwards, mutant mice
exhibited increased body weight. By 12 weeks of age, POMCDicerKO
mice were 13% heavier than control counterparts (Figure 2A) and
showed increased epididymal fat weight (Figure 2B) suggesting higher
adiposity. Consistent with this phenotype, plasma leptin (Figure 2C)
and blood triglycerides concentration (Figure 2D) were significantlyFigure 4: POMCDicerKO mice exhibit pituitary dysplasia. (A) General pituitary morphology assessed by Haematoxylin-Eosin sta
(G) FSH. Representative images from 12-week old male control and POMCDicerKO mice are shown (n¼3 mice/genotype). IL: in
120x. (H) Pituitary gene expression profile in 12-week old male control and POMCDicerKO mice (n¼5 mice/genotype) assess
**Po0.01.
MOLECULAR METABOLISM 2 (2013) 74–85 & 2012 Elsevier GmbH. All rights reserved. www.molecincreased in mutant mice. POMCDicerKO mice displayed hyperphagia
(Figure 2E) and increased rebound food intake after a fast-refeeding
paradigm (Figure 2F). Twelve-week old mutant mice also displayed
hyperglycemia under fed and fasting conditions (Figure 3A), hyper-
insulinemia (Figure 3B), glucose intolerance (Figure 3C; Area under the
curve (AUC) control: 23,9957652 mg/dl/120 min; AUC POMCDicerKO:
28,3527725 mg/dl/120 min; n¼6–8 mice/genotype, Po0.001) and
insulin resistance (Figure 3D). Defective glucose homeostasis in
POMCDicerKO mice was secondary to obesity development, since
mutant mice at 6 weeks of age did not exhibit altered glucose
metabolism parameters (Figure 3E–H). Female POMCDicerKO mice
showed essentially the same phenotype as males, in terms of both
energy balance and glucose metabolism (data not shown).
3.4. POMCDicerKO mice exhibit alterations in pituitary-adrenal axis
function
POMC promoter drives cre recombinase expression in the pituitary and the
hypothalamus [18], and therefore we undertook studies to assess these
tissues. Pituitary Dicer mRNA was reduced by 40% in 12-week
old male mutant mice (control: 10075%; POMCDicerKO: 5975%;
n¼5 mice/genotype, Po0.001). Immunohistochemical studies revealedining. Hormone-specific pituitary immunohistochemistry was performed for (B) ACTH, (C) GH, (D) TSH (E), PRL (F) LH and
termediate lobe. NP: neurohypophysis. MZ: Marginal Zone. AP: adenopituitary. All images were taken at 60x except inserts at
ed by qPCR. Probe for Gapdh was used to adjust for total RNA content. Data are expressed as mean7SEM. *Po0.05;
ularmetabolism.com 79
Original articlelack of pituitary intermediate lobe (Figure 4A) and a dramatic reduction
of adrenocorticotropic hormone (ACTH) positive cells in the adenopituitary
of POMCDicerKO mice (control: 1078774 cells; POMCDicerKO: 467
7 cells; n¼3 mice/genotype, Po0.01 and Figure 4B). Interestingly,
mutant mice showed small clusters of ACTH-positive cells in the marginal
zone (Figure 4B, insets), suggesting de novo regeneration from progenitor
cells [35]. Staining for growth hormone (GH), thyroid-stimulating hormone
(TSH), prolactin (PRL), luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) was unaltered (Figure 4C–G). Consistently, expression of
melanotroph and corticotroph specific genes such as Pomc, T box
transcription factor (Tpit ) and corticotrophin releasing hormone receptor 1
(Crhr1) were significantly downregulated (Figure 4H), while essential genes
for the generation of other pituitary lineages such as pituitary-specific
transcription factor 1 (Pit-1), growth hormone (Gh) and thyroid-stimulating
hormone beta chain (Tshb) were unchanged in POMCDicerKO mice
(Figure 4H). Adrenal gland morphology was also abnormal in POMCDicerKO
mice, exhibiting reduced size and cortex hypoplasia affecting the fascicular
and reticular zones (Figure 5A and B). Basal plasma corticosterone levels
were reduced by 80% and the response to stress was blunted
(Figure 5C). However, adrenal medullas were normal with strong positivity
for tyrosine hydroxylase (data not shown). Plasma epinephrine was slightly
reduced while norepinephrine and dopamine unaltered (Figure 5D).
Collectively, these results indicate that deletion of Dicer in pituitary
POMC-expressing cells lead to dysfunction of the pituitary-adrenal axis
and secondary hypoadrenalism.
3.5. POMCDicerKO mice exhibit POMC neuron degeneration
To further investigate the mechanisms underlying the obese phenotype,
we next analyzed the expression of neuropeptides and relevant
melanocortin pathway genes in the hypothalamus of 12-week old
male control and POMCDicerKO mice. Pomc and Cart mRNA levels
were undetectable (Figure 6A), while AgRP and Npy transcripts
were reduced in mutant mice (Figure 6A). The expression levels of
corticotropin-releasing hormone (Crh), melanocortin receptor 3 (Mc3r)
and 4 (Mc4r) were also reduced (Figure 6B).
Given that miRNAs are implicated in neuronal development, survival and
function we hypothesized that undetectable Pomc and Cart expression inFigure 5: POMCDicerKO mice exhibit adrenal hypofunction. (A, B) Adrenal gland Haematoxylin–Eosin staining. Representative im
Glomerular zone. Fa: Fascicular zone. Re: Reticular zone. (C) Plasma corticosterone, (D) epinephrine, norepinephine and dopam
*Po0.05; **Po0.01.
80 MOLECULAR METABthe hypothalamus from POMCDicerKO mice (Figure 6A) was the
consequence of POMC neuron degeneration (both neuropeptides colo-
calize in ARC POMC neurons). To test this hypothesis, we performed
a systematic immunohistochemical analysis throughout the ARC in
12-week old POMCDicerKO mice and failed to detect POMC neurons
or POMC-positive fibers (Figure 6C and D). No gross neuroanatomical
abnormalities were observed. To determine the temporal pattern of
POMC neuron disappearance, we conducted gene expression studies
during post-natal development and early adulthood. As described [36],
hypothalamic Pomc mRNA in control mice was stable during the lactation
period and increased between weaning and early adulthood (Figure 6E).
In POMCDicerKO mice, Pomc expression was unaltered during the first
two weeks of life but was significantly reduced at 3 weeks of age and
undetectable at 6 weeks of age (Figure 6E). A similar pattern of
expression was observed for Cart (Figure 6F). Consistent with this data,
immunohistochemistry studies showed a significant 70% reduction
in POMC neuron number in the ARC from 3-week old POMCDicerKO
mice (Figure 6G and H). The density of POMC-positive fibers was
also dramatically reduced (Figure 6G). Collectively, our results show
evidence of altered POMC neuron function and features, associated with
the development of a pathological condition suggestive of selective
neurodegeneration.
In an attempt to reveal the molecular alterations leading to POMC
neurodegeneration, we performed a global transcriptomic analysis
in hypothalamic microdissections from presymptomatic 2-week old
control and POMCDicerKO mice. We found 246 downregulated and 157
upregulated genes in hypothalami from POMCDicerKO mice when
compared to controls (Figure 7A and Supplemental Tables 1 and 2).
To establish potential dysregulated pathways, we conducted gene
ontology and KEGG pathway analyses. Downregulated categories
included MAPK signaling, lysosome, ubiquitin-mediated proteolysis and
ribosome (Figure 7B). Representative genes for each biological pathway
were validated by qPCR (Figure 7C). Expression of transcriptional
markers for astrocytes (Gfap, Aldh1L1) and microglia (Cd34, Itgam,
Aif, Emr1) were unaltered (data not shown) suggesting that, at least at
this stage, gliosis or microglial infiltration were not associated with
POMC neuron degeneration.ages from 12-week old male control and POMCDicerKO mice are shown (n¼3 mice/genotype). Me: Medula. Cx: Cortex. Gl:
ine in 12-week old male control and POMCDicerKO mice. Data are expressed as mean7SEM. N¼6–7 mice/genotype.
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Figure 6: Dicer deletion in POMC neurons leads to neurodegeneration. (A) Hypothalamic neuropeptides and (B) melanocortin pathway genes in 12-week old male control and POMCDicerKO mice assessed by qPCR (n¼6–8 mice/genotype). (C) POMC
immunofluorescence and (D) neuron counts throughout the ARC of 12-week old male control and POMCDicerKO mice (n¼3 mice/genotype). (E) Temporal pattern of Pomc and (F) Cart mRNA expression in the hypothalamus from control and POMCDicerKO
mice during post-natal and early adulthood (n¼5–9 mice/genotype). (G) POMC immunofluorescence and (H) neuron counts throughout the ARC of 3-week old male control and POMCDicerKO mice (n¼3 mice/genotype). 3V: third ventricle. UD:
undetectable. Mean7SEM. *Po0.05; **Po0.01; ***Po0.001.
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Figure 7: Hypothalamic global transcriptomic studies in POMCDicerKO mice. (A) Heatmap representation of relative gene expression changes in hypothalamic microdissections from 2-week old male control and POMCDicerKO mice (n¼3 mice/genotype).
(B) Representative downregulated genes by KEGG pathway analysis. (C) qPCR validation of representative genes found to be downregulated by microarray analysis. Data are expressed as mean7SEM. **Po0.01.
Original article4. DISCUSSION
A large body of evidence indicates that miRNAs play a major role in
proliferation, differentiation and survival of a wide range of neuronal
and non-neuronal cell-types of the CNS [5–9]. Consistent with these
observations, deletion of Dicer in hypothalamic POMC neurons leads to
neurodegeneration, a term which refers to loss of both neuronal82 MOLECULAR METABfunction and structure. This process starts between 2 and 3 weeks of
age and is completed around 6 weeks of age. This data indicate that
Dicer-derived miRNAs are essential for survival and maintenance of POMC
neurons during post-natal and early adulthood, but are not necessary to
establish the POMC neuron lineage. This notion is in line with other
conditional Dicer knock-out models that also suggest the absence of
any relevant function for Dicer/miRNAs in early cell-fate decisions.OLISM 2 (2013) 74–85 & 2012 Elsevier GmbH. All rights reserved. www.molecularmetabolism.com
However, it cannot be ruled out a potential role for Dicer-independent
miRNAs in the establishment of the POMC neuron lineage.
POMC neuron loss is paralleled by a 40–50% reduction in Npy and
AgRP transcript expression. This observation could be the consequence
of altered NPY/AgRP neurocircuitry, but preliminary data suggest that
the distribution of AgRP-positive fibers throughout the ARC is unaltered
in POMCDicerKO mice (M.S. and M.C., unpublished results). This data
suggest that decreased expression of these orexigenic neuropeptides
may reflect a compensatory mechanism to counteract the orexigenic
tone induced by POMC neuron loss, rather than alterations in the
establishment of the AgRP neuronal network.
Our global transcriptomic analysis showed that the altered early
molecular neurodegenerative events found in POMCDicerKO mice were
linked to defective MAPK signaling, lysosome, ubiquitin proteosome
system (UPS) and ribosome function. Interestingly, these pathways
have been associated with classical neurodegenerative disorders. For
example, UPS and autophagy dysfunction have been widely implicated
in the accumulation of damaged organelles and protein aggregates in
Parkinson’s and Alzheimer diseases [37,38]. Parkin expression, a key
component of the E3 ubiquitin ligase complex and the most common
genetic alteration in autosomal recessive Parkinson’s disease [39,40],
was reduced in POMCDicerKO mice. Furthermore, recent evidences
indicate that ribosome biogenesis and delivery to specific areas is
essential for neuronal growth, maintenance and synaptic plasticity and,
therefore, failure of ribosome production may underlie neurodegenera-
tion. In fact, nucleolus dysfunction has been reported in a number of
neurodegenerative disorders [41]. The role of the ERK/MAPK pathway in
neurons is more controversial, but commonly associated with neuronal
survival, proliferation, differentiation, synaptic plasticity [42] as well as
neuroprotective processes [43,44]. Collectively, these results suggest
that the POMC degeneration observed in POMCDicerKO mice shares
striking similarities with common neurodegenerative disorders.
Several studies have recently linked hypothalamic neurodegeneration
with obesity [45,46], and it has been recently reported that high-fat
diet administration leads to reduced POMC neuron number in the
ARC [47,48]. Furthermore, either acute [49] or progressive [19] POMC
neuron loss results in body weight gain. Consistent with these observations,
POMC neurodegeneration in POMCDicerKO mice resulted in increased
orexigenic tone and obesity, characterized by hyperphagia, increased
adiposity and secondary alterations in glucose metabolism. Although the
magnitude and onset of the phenotypes exhibited by POMC ablated mice
are different, acute POMC ablation, either in the adult [49] or during
development (present manuscript), lead to a similar phenotype suggesting
lack of neuronal plasticity and developmental compensations [50].
In relation to pituitary function, our gene expression analysis showed
reduced expression of specific melanotroph and corticotroph genes (Pomc,
Tpit and Crhr1) and lack of ACTH staining in POMCDicerKO mice. These
results indicate survival defects of pituitary melanotrophs and corticotrophs,
which is consistent with the lack of the intermedial lobe and the deletion of
Dicer specifically in these cell types. The abnormal functionality of the
pituitary–adrenal axis was further confirmed by secondary alterations in
adrenal gland morphology and reduced plasma concentrations of corticos-
terone and epinephrine in POMCDicerKO mice. Most forms of human
and rodent obesity are associated with high glucocorticoid levels, while
corticosterone deficiency induces weight loss and hypophagia [51]. There-
fore, it is very unlikely that hypocortisolism contributes to the obese
phenotype observed in mice lacking Dicer in POMC-expressing cells.
In fact, restoration of circulating corticosterone in POMC knock-out [52]
or POMC-neuron ablated mice [19] leads to a more pronounced hyperphagia
and obese phenotype. Although the defects in the neuroendocrine axis areMOLECULAR METABOLISM 2 (2013) 74–85 & 2012 Elsevier GmbH. All rights reserved. www.moleclikely to be a direct consequence of Dicer deletion in the pituitary, we cannot
exclude that part of these alterations are due to hypothalamic defects since
Crh expression, a neuropeptide implicated in the pituitary synthesis of ACTH,
was decreased in POMCDicerKO mice.
Recent reports have demonstrated that miRNAs are critical regulators of
glucose and lipid metabolism and therefore have been suggested to play a
role in the development of metabolic conditions such as obesity, diabetes
and metabolic syndrome [4]. Our results show that Dicer is expressed in
critical hypothalamic areas and neurons implicated in energy balance
control, and that its expression in the hypothalamus is modulated by
nutrient availability, pathophysiological conditions of nutrient excess and
genetic obesity. Interestingly, Dicer gene expression has been also reported
to be reduced in liver and muscle biopsies from insulin-resistant obese
patients [53]. Thus, our results suggest a potential role for Dicer in the
hypothalamic regulation of energy homeostasis in adult mice. Unfortu-
nately, due to early POMC neuron degeneration, this hypothesis could not
be addressed using our POMCDicerKO model and should be formally
investigated using alternative approaches such as viral-mediated knock-
down strategies or inducible cre/lox system.
In conclusion, this study demonstrates that deletion of Dicer in POMC
neurons leads to neurodegeneration and early onset of obesity and
associated metabolic alterations. These data highlight the importance of
miRNAs in the survival of hypothalamic POMC neurons and their involvement
in the maintenance of key neuronal circuits implicated in energy balance
regulation during development. POMCDicerKO mice could represent a useful
model for the study of early-onset neurodegenerative obesity.ACKNOWLEDGMENTS
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